News & Analysis on Clinical Trial Services & Contract Research And Development
Phase II and III research is expected to see the biggest upturn in terms of outsourcing from large and medium-sized pharma, according to a survey from the Life Sciences Strategy Group.
The European Medicines Agency (EMA) has abandoned plans to stop researchers downloading clinical trial data but the European Ombudsman says she is unaware if other limits on transparency remain.
A US presidential report on plans to improve chemical facility safety and security has incorporated a number of recommendations from the Society of Chemical Manufacturers and Affiliates (SOCMA).
Following its merger with RPS, as well as a number of other acquisitive moves, CRO PRA will now be known as PRA Health Sciences and will look to continue to establish itself as a top 5 CRO in the world.
Two billion cartridges of inhaled insulin drug Afrezza will be manufactured annually by Mannkind, the firm says as it awaits final approval next month.